Johnson & Johnson Completes Acquisition of Shockwave Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Johnson & Johnson (JNJ) ordered to pay $260 million in talc trial - Reuters
June 4, 2024 9:16 AM EDTAccording to a report from Reuters on Tuesday, Johnson & Johnson (NYSE: JNJ) must pay $260 million to an Oregon woman who said she developed mesothelioma, a cancer linked to asbestos exposure from inhaling the company's talc powder.
The verdict includes $60 million in compensatory damages and $200 million in... More
